Advertisement
ABX vs MET
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABX is a StrongBuy and MET is a Buy.
ABX's RSI Oscillator recovers from oversold territory
The RSI Indicator for ABX moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 10 similar instances when the indicator left oversold territory. In 8 of the 10 cases the stock moved higher. This puts the odds of a move higher at 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on ABX as a result. In 60 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for ABX just turned positive on October 06, 2026. Looking at past instances where ABX's MACD turned positive, the stock continued to rise in 30 of 57 cases over the following month. The odds of a continued upward trend are 53%.
Following a +1.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABX advanced for three days, in 145 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
ABX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for ABX moved below the 200-day moving average on October 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for ABX entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. ABX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.915) is normal, around the industry mean (1.347). P/E Ratio (29.345) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.046) among similar stocks. ABX's P/S Ratio (3.453) is very high in comparison to the industry average of (1.303).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
MET in +2.36% Uptrend, growing for three consecutive days on October 22, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on October 08, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 28 of 51 cases over the following month. The odds of a continued upward trend are 55%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 15 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.398) is slightly higher than the industry average of (1.347). P/E Ratio (19.690) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.023) settles around the average of (0.046) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ABX | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 44 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 55 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 19 | |
SMR RATING 1..100 | 80 | 99 | |
PRICE GROWTH RATING 1..100 | 48 | 15 | |
P/E GROWTH RATING 1..100 | 96 | 11 | |
SEASONALITY SCORE 1..100 | 35 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (55) in the Life Or Health Insurance industry is in the same range as ABX (85) in the Precious Metals industry. This means that MET’s stock grew similarly to ABX’s over the last 12 months.
MET's Profit vs Risk Rating (19) in the Life Or Health Insurance industry is significantly better than the same rating for ABX (100) in the Precious Metals industry. This means that MET’s stock grew significantly faster than ABX’s over the last 12 months.
ABX's SMR Rating (80) in the Precious Metals industry is in the same range as MET (99) in the Life Or Health Insurance industry. This means that ABX’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for ABX (48) in the Precious Metals industry. This means that MET’s stock grew somewhat faster than ABX’s over the last 12 months.
MET's P/E Growth Rating (11) in the Life Or Health Insurance industry is significantly better than the same rating for ABX (96) in the Precious Metals industry. This means that MET’s stock grew significantly faster than ABX’s over the last 12 months.
| ABX | MET | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 80% | 1 day ago 55% |
| Stochastic ODDS (%) | 1 day ago 40% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 58% | 1 day ago 54% |
| MACD ODDS (%) | 1 day ago 53% | 1 day ago 55% |
| TrendWeek ODDS (%) | 1 day ago 46% | 1 day ago 60% |
| TrendMonth ODDS (%) | 1 day ago 46% | 1 day ago 54% |
| Advances ODDS (%) | 1 day ago 70% | 1 day ago 65% |
| Declines ODDS (%) | 12 days ago 77% | 24 days ago 52% |
| BollingerBands ODDS (%) | 1 day ago 77% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 73% | 1 day ago 47% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABX’s FA Score shows that 0 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s).
- ABX’s FA Score: 0 green, 5 red.
- MET’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABX’s TA Score shows that 5 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).
- ABX’s TA Score: 5 bullish, 4 bearish.
- MET’s TA Score: 5 bullish, 5 bearish.
Price Growth
ABX (@Life/Health Insurance) experienced а +7.45% price change this week, while MET (@Life/Health Insurance) price change was +3.29% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +3.54%. For the same industry, the average monthly price growth was -0.35%, and the average quarterly price growth was -1.67%.
Reported Earning Dates
ABX is expected to report earnings on Nov 05, 2026.
MET is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Life/Health Insurance (+3.54% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
ABX and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABX has been loosely correlated with LNC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ABX jumps, then LNC could also see price increases.
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.